Patient Group Direction (PGD) for Ipratropium Bromide
£149.00
Ipratropium Bromide is a drug used in the treatment of breathing difficulties. This PGD will allow your staff to administer Ipratropium Bromide in the same way as a statutory ambulance service.
The PGD will be delivered electronically, within 10 working days, to your Registered Manager for signature. Once signed, it will be sent to up to 50 staff for signature using our e-signing service, and will remain valid for one year.
By purchasing this product, you agree you are a CQC registered firm and your registration currently includes the treatment of injury disease or disorder.
For more information on our PGD solutions, please click here. If you are unsure whether this product meets the needs of your service, please contact us for more information.
Information on Ipratropium Bromide can be found in the British National Formulary.
